Cargando…

BioMOF-Based Anti-Cancer Drug Delivery Systems

A variety of nanomaterials have been developed specifically for biomedical applications, such as drug delivery in cancer treatment. These materials involve both synthetic and natural nanoparticles and nanofibers of varying dimensions. The efficacy of a drug delivery system (DDS) depends on its bioco...

Descripción completa

Detalles Bibliográficos
Autores principales: Elmehrath, Sandy, Nguyen, Ha L., Karam, Sherif M., Amin, Amr, Greish, Yaser E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005089/
https://www.ncbi.nlm.nih.gov/pubmed/36903831
http://dx.doi.org/10.3390/nano13050953
_version_ 1784904994332344320
author Elmehrath, Sandy
Nguyen, Ha L.
Karam, Sherif M.
Amin, Amr
Greish, Yaser E.
author_facet Elmehrath, Sandy
Nguyen, Ha L.
Karam, Sherif M.
Amin, Amr
Greish, Yaser E.
author_sort Elmehrath, Sandy
collection PubMed
description A variety of nanomaterials have been developed specifically for biomedical applications, such as drug delivery in cancer treatment. These materials involve both synthetic and natural nanoparticles and nanofibers of varying dimensions. The efficacy of a drug delivery system (DDS) depends on its biocompatibility, intrinsic high surface area, high interconnected porosity, and chemical functionality. Recent advances in metal-organic framework (MOF) nanostructures have led to the achievement of these desirable features. MOFs consist of metal ions and organic linkers that are assembled in different geometries and can be produced in 0, 1, 2, or 3 dimensions. The defining features of MOFs are their outstanding surface area, interconnected porosity, and variable chemical functionality, which enable an endless range of modalities for loading drugs into their hierarchical structures. MOFs, coupled with biocompatibility requisites, are now regarded as highly successful DDSs for the treatment of diverse diseases. This review aims to present the development and applications of DDSs based on chemically-functionalized MOF nanostructures in the context of cancer treatment. A concise overview of the structure, synthesis, and mode of action of MOF-DDS is provided.
format Online
Article
Text
id pubmed-10005089
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100050892023-03-11 BioMOF-Based Anti-Cancer Drug Delivery Systems Elmehrath, Sandy Nguyen, Ha L. Karam, Sherif M. Amin, Amr Greish, Yaser E. Nanomaterials (Basel) Review A variety of nanomaterials have been developed specifically for biomedical applications, such as drug delivery in cancer treatment. These materials involve both synthetic and natural nanoparticles and nanofibers of varying dimensions. The efficacy of a drug delivery system (DDS) depends on its biocompatibility, intrinsic high surface area, high interconnected porosity, and chemical functionality. Recent advances in metal-organic framework (MOF) nanostructures have led to the achievement of these desirable features. MOFs consist of metal ions and organic linkers that are assembled in different geometries and can be produced in 0, 1, 2, or 3 dimensions. The defining features of MOFs are their outstanding surface area, interconnected porosity, and variable chemical functionality, which enable an endless range of modalities for loading drugs into their hierarchical structures. MOFs, coupled with biocompatibility requisites, are now regarded as highly successful DDSs for the treatment of diverse diseases. This review aims to present the development and applications of DDSs based on chemically-functionalized MOF nanostructures in the context of cancer treatment. A concise overview of the structure, synthesis, and mode of action of MOF-DDS is provided. MDPI 2023-03-06 /pmc/articles/PMC10005089/ /pubmed/36903831 http://dx.doi.org/10.3390/nano13050953 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Elmehrath, Sandy
Nguyen, Ha L.
Karam, Sherif M.
Amin, Amr
Greish, Yaser E.
BioMOF-Based Anti-Cancer Drug Delivery Systems
title BioMOF-Based Anti-Cancer Drug Delivery Systems
title_full BioMOF-Based Anti-Cancer Drug Delivery Systems
title_fullStr BioMOF-Based Anti-Cancer Drug Delivery Systems
title_full_unstemmed BioMOF-Based Anti-Cancer Drug Delivery Systems
title_short BioMOF-Based Anti-Cancer Drug Delivery Systems
title_sort biomof-based anti-cancer drug delivery systems
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005089/
https://www.ncbi.nlm.nih.gov/pubmed/36903831
http://dx.doi.org/10.3390/nano13050953
work_keys_str_mv AT elmehrathsandy biomofbasedanticancerdrugdeliverysystems
AT nguyenhal biomofbasedanticancerdrugdeliverysystems
AT karamsherifm biomofbasedanticancerdrugdeliverysystems
AT aminamr biomofbasedanticancerdrugdeliverysystems
AT greishyasere biomofbasedanticancerdrugdeliverysystems